Optimizing cardiac surgery outcomes in morbid obesity: Surgical, anesthetic, perfusion, and critical care considerations, a narrative review.

The journal of extra-corporeal technology Pub Date : 2026-09-01 Epub Date: 2026-09-15 DOI:10.1051/ject/2026021
Salman Pervaiz Butt, Salman Abdulaziz, Nabeel Razzaq, Rhea Anand, Nilesh Srivatav, Yasir Saleem, Olga Lender, Mairead Griffin, Azreen Afzal, Vivek Kakar, Fazil Ashiq, Arun Kumar, Arshad Ghori, Jehad Ramahi, Mitesh Badiwala, Umer Darr, Gopal Bhatnagar
{"title":"Optimizing cardiac surgery outcomes in morbid obesity: Surgical, anesthetic, perfusion, and critical care considerations, a narrative review.","authors":"Salman Pervaiz Butt, Salman Abdulaziz, Nabeel Razzaq, Rhea Anand, Nilesh Srivatav, Yasir Saleem, Olga Lender, Mairead Griffin, Azreen Afzal, Vivek Kakar, Fazil Ashiq, Arun Kumar, Arshad Ghori, Jehad Ramahi, Mitesh Badiwala, Umer Darr, Gopal Bhatnagar","doi":"10.1051/ject/2026021","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The global prevalence of morbid obesity is increasing, presenting challenges in cardiac surgery. Morbid obesity (body mass index ≥40 kg/m<sup>2</sup>) is associated with a high burden of cardiometabolic comorbidities and obesity-specific physiological alterations that increase perioperative risk and complicate surgical, anesthetic, and cardiopulmonary bypass management. As the number of obese patients presenting for cardiac surgery rises, a synthesis of current evidence and perioperative strategies is needed to optimize outcomes in this high-risk population.</p><p><strong>Methods: </strong>This narrative review identified relevant literature through targeted searches of PubMed and Google Scholar, supplemented by screening the reference lists of key articles. Search terms included combinations of \"cardiac surgery,\" \"morbid obesity,\" \"obesity,\" \"cardiopulmonary bypass,\" \"anesthesia,\" \"perfusion,\" \"postoperative complications,\" and \"critical care.\" Studies were mapped to perioperative domains, including anesthesia and respiratory management, surgical and wound-related considerations, perfusion and cardiopulmonary bypass strategy, intensive care unit (ICU) outcomes, renal complications, atrial fibrillation, bleeding, thromboembolism, and mortality. The evidence base was predominantly observational and review-based, with limited randomized evidence.</p><p><strong>Discussion: </strong>Obesity poses multifactorial challenges in cardiovascular surgery by altering cardiac morphology, hemodynamics, and perioperative outcomes. Associated comorbidities such as diabetes, obstructive sleep apnea, and pulmonary hypertension increase operative risk and complicate anesthetic and perfusion management. Obese patients demonstrate altered pharmacokinetics, reduced pulmonary compliance, and heightened inflammation, requiring individualized strategies. Available evidence suggests that lean body mass-informed perfusion, selected off-pump CABG, and early extubation may reduce complications, although high-quality randomized evidence remains limited.</p><p><strong>Conclusion: </strong>Cardiac surgery in morbidly obese patients requires a coordinated, physiology-driven perioperative strategy to address obesity-specific anatomical and functional challenges. Tailored anesthetic, perfusion, and surgical approaches, supported by close multidisciplinary collaboration, are central to optimizing outcomes. Further research is needed to refine perioperative protocols, improve risk stratification beyond BMI, and clarify long-term cardiovascular outcomes following surgery in this population.</p>","PeriodicalId":519952,"journal":{"name":"The journal of extra-corporeal technology","volume":"58 3","pages":"301-312"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13577622/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of extra-corporeal technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1051/ject/2026021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The global prevalence of morbid obesity is increasing, presenting challenges in cardiac surgery. Morbid obesity (body mass index ≥40 kg/m2) is associated with a high burden of cardiometabolic comorbidities and obesity-specific physiological alterations that increase perioperative risk and complicate surgical, anesthetic, and cardiopulmonary bypass management. As the number of obese patients presenting for cardiac surgery rises, a synthesis of current evidence and perioperative strategies is needed to optimize outcomes in this high-risk population.

Methods: This narrative review identified relevant literature through targeted searches of PubMed and Google Scholar, supplemented by screening the reference lists of key articles. Search terms included combinations of "cardiac surgery," "morbid obesity," "obesity," "cardiopulmonary bypass," "anesthesia," "perfusion," "postoperative complications," and "critical care." Studies were mapped to perioperative domains, including anesthesia and respiratory management, surgical and wound-related considerations, perfusion and cardiopulmonary bypass strategy, intensive care unit (ICU) outcomes, renal complications, atrial fibrillation, bleeding, thromboembolism, and mortality. The evidence base was predominantly observational and review-based, with limited randomized evidence.

Discussion: Obesity poses multifactorial challenges in cardiovascular surgery by altering cardiac morphology, hemodynamics, and perioperative outcomes. Associated comorbidities such as diabetes, obstructive sleep apnea, and pulmonary hypertension increase operative risk and complicate anesthetic and perfusion management. Obese patients demonstrate altered pharmacokinetics, reduced pulmonary compliance, and heightened inflammation, requiring individualized strategies. Available evidence suggests that lean body mass-informed perfusion, selected off-pump CABG, and early extubation may reduce complications, although high-quality randomized evidence remains limited.

Conclusion: Cardiac surgery in morbidly obese patients requires a coordinated, physiology-driven perioperative strategy to address obesity-specific anatomical and functional challenges. Tailored anesthetic, perfusion, and surgical approaches, supported by close multidisciplinary collaboration, are central to optimizing outcomes. Further research is needed to refine perioperative protocols, improve risk stratification beyond BMI, and clarify long-term cardiovascular outcomes following surgery in this population.

在病态肥胖中优化心脏手术的结果:手术、麻醉、灌注和危重护理的考虑,一个叙述性的回顾。
导读:全球肥胖症患病率正在上升,这对心脏外科手术提出了挑战。病态肥胖(体重指数≥40 kg/m2)与心脏代谢合并症和肥胖特异性生理改变的高负担相关,这些改变会增加围手术期风险,并使手术、麻醉和体外循环管理复杂化。随着接受心脏手术的肥胖患者数量的增加,需要综合目前的证据和围手术期策略来优化这一高危人群的预后。方法:通过对PubMed和谷歌Scholar进行针对性检索,并辅以筛选关键文章的参考文献列表,确定相关文献。搜索词包括“心脏手术”、“病态肥胖”、“肥胖”、“体外循环”、“麻醉”、“灌注”、“术后并发症”和“重症监护”的组合。研究被映射到围手术期领域,包括麻醉和呼吸管理、手术和伤口相关的考虑、灌注和体外循环策略、重症监护病房(ICU)结果、肾脏并发症、心房颤动、出血、血栓栓塞和死亡率。证据基础主要是观察性和综述性的,随机证据有限。讨论:肥胖通过改变心脏形态、血流动力学和围手术期结果,给心血管手术带来了多因素挑战。相关合并症如糖尿病、阻塞性睡眠呼吸暂停和肺动脉高压增加手术风险并使麻醉和灌注管理复杂化。肥胖患者表现出药代动力学改变、肺顺应性降低和炎症加剧,需要个体化治疗。尽管高质量的随机证据仍然有限,但现有证据表明,瘦体质量知情灌注、选择性非泵送冠脉搭桥和早期拔管可以减少并发症。结论:病态肥胖患者的心脏手术需要一个协调的、生理驱动的围手术期策略来解决肥胖特异性的解剖和功能挑战。在密切的多学科合作的支持下,量身定制的麻醉、灌注和手术入路是优化结果的核心。需要进一步的研究来完善围手术期方案,改善BMI以外的风险分层,并明确该人群手术后的长期心血管结局。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书